| ENLV Stock | | | USD 1.14 0.07 6.54% |
Enlivex Therapeutics financial indicator trend analysis is much more than just examining Enlivex Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Enlivex Therapeutics is a good investment. Please check the relationship between Enlivex Therapeutics Preferred Stock Total Equity and its Accounts Payable accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enlivex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Enlivex Stock please use our
How to Invest in Enlivex Therapeutics guide.
Preferred Stock Total Equity vs Accounts Payable
Preferred Stock Total Equity vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Enlivex Therapeutics Preferred Stock Total Equity account and
Accounts Payable. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Enlivex Therapeutics' Preferred Stock Total Equity and Accounts Payable is -0.65. Overlapping area represents the amount of variation of Preferred Stock Total Equity that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Enlivex Therapeutics, assuming nothing else is changed. The correlation between historical values of Enlivex Therapeutics' Preferred Stock Total Equity and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Preferred Stock Total Equity of Enlivex Therapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Preferred Stock Total Equity i.e., Enlivex Therapeutics' Preferred Stock Total Equity and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.65 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Preferred Stock Total Equity
Accounts Payable
An accounting item on the balance sheet that represents Enlivex Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Enlivex Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Enlivex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Enlivex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enlivex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Enlivex Stock please use our
How to Invest in Enlivex Therapeutics guide.
Selling General Administrative is likely to climb to about 8.1
M in 2024, despite the fact that
Tax Provision is likely to grow to (3.4
K).
Enlivex Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Enlivex Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Enlivex Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Enlivex Stock Analysis
When running Enlivex Therapeutics' price analysis, check to
measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.